Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjosé, MA Clarke… - The Lancet …, 2022 - thelancet.com
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …
被引用次数：50 相关文章

[引用][C] Re:“Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis”

PG Rossi, M Rebolj - The Lancet Oncology, 2022 - kclpure.kcl.ac.uk
Re: “Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a
systematic review and meta-analysis” — King's College London Skip to main navigation Skip …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjose… - LANCET …, 2022 - avesis.hacettepe.edu.tr
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjosé, MA Clarke… - The Lancet …, 2022 - thelancet.com
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjosé, MA Clarke… - The Lancet …, 2022 - Elsevier
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.

M Arbyn, M Simon, S de Sanjosé, MA Clarke… - The Lancet …, 2022 - europepmc.org
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjose, MA Clarke… - LANCET …, 2022 - biblio.ugent.be
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …
[PDF] imi.si

[PDF][PDF] Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjosé, MA Clarke, M Poljak… - Lancet Oncol, 2022 - imi.si
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjosé… - The Lancet …, 2022 - researchinformation.amsterdamumc …
Background: Cervical cancer screening tests that identify DNA of the main causal agent,
high-risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

M Arbyn, M Simon, S de Sanjosé… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …